OAC
VRTX icon

OMERS Administration Corp’s Vertex Pharmaceuticals VRTX Stock Holding History

OMERS Administration Corp’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.39M Buy
18,797
+3,318
+21% +$1.55M 0.05% 161
2025
Q4 		$7.02M Buy
15,479
+1,725
+13% +$744K 0.05% 151
2025
Q3 		$5.39M Hold
13,754
– – 0.04% 177
2025
Q2 		$6.12M Buy
13,754
+100
+0.7% +$46.1K 0.05% 144
2025
Q1 		$6.62M Sell
13,654
-88
-0.6% -$41K 0.06% 137
2024
Q4 		$5.53M Sell
13,742
-1,213
-8% -$562K 0.05% 148
2024
Q3 		$6.96M Buy
14,955
+400
+3% +$192K 0.06% 131
2024
Q2 		$6.82M Buy
+14,555
New +$6.32M 0.07% 135

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

OMERS Administration Corp's VRTX Position: Q1 2026 in Review

OMERS Administration Corp increased its Vertex Pharmaceuticals (VRTX) stake by 21% in Q1 2026, buying an estimated $1.55M and bringing the position to 18,797 shares worth $8.39M. The position accounts for 0.05% of the portfolio, ranked #161.

OMERS Administration Corp first reported a position in VRTX in Q2 2024 and has held it in 8 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • OMERS Administration Corp held 18,797 shares of Vertex Pharmaceuticals worth $8.39M as of Q1 2026.
  • OMERS Administration Corp bought 3,318 Vertex Pharmaceuticals shares in Q1 2026, an estimated $1.55M.
  • Vertex Pharmaceuticals made up 0.05% of OMERS Administration Corp's portfolio in Q1 2026, its #161 holding.
  • OMERS Administration Corp first reported a position in Vertex Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.